Efficacy and safety of the first parenteral selective COX-2 inhibitor, parecoxib sodium, in adult patients with postoperative pain.
2003 · PubMed · 1 citations
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
93
Citations
5
h-index
4
i10-index
Shivpreet Singh Samra is an academic researcher from Cancer Research UK Cambridge Center. The author has contributed to research in topics: Blood Pressure and Hypertension Studies & Neuroendocrine Tumor Research Advances & Myasthenia Gravis and Thymoma. The author has an h-index of 5, co-authored 13 publications.
Click to start Chat